6A93
Crystal structure of 5-HT2AR in complex with risperidone
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SPRING-8 BEAMLINE BL32XU |
Synchrotron site | SPring-8 |
Beamline | BL32XU |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2016-12-15 |
Detector | RAYONIX MX225-HS |
Wavelength(s) | 1.0 |
Spacegroup name | C 1 2 1 |
Unit cell lengths | 277.720, 42.150, 91.940 |
Unit cell angles | 90.00, 92.55, 90.00 |
Refinement procedure
Resolution | 46.241 - 3.000 |
R-factor | 0.2452 |
Rwork | 0.243 |
R-free | 0.27470 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2rh1 |
RMSD bond length | 0.003 |
RMSD bond angle | 0.651 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHASER |
Refinement software | PHENIX ((dev_3150)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 46.241 | 2.800 |
High resolution limit [Å] | 2.707 | 2.707 |
Number of reflections | 29971 | |
<I/σ(I)> | 6.63 | |
Completeness [%] | 84.0 | |
Redundancy | 22.4 | |
CC(1/2) | 0.993 | 0.677 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | LIPIDIC CUBIC PHASE | 293 | 100 mM MES, pH 6.0-6.5, 28-31% (v/v) PEG 400, 120-200 mM Am-formate, 1-2% (v/v) DMSO |